+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neurological Drug"

From
Rare Neurological Disease Treatment Market Report 2026 - Product Thumbnail Image

Rare Neurological Disease Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Neurological Disorder Drugs Market Report 2026 - Product Thumbnail Image

Neurological Disorder Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Rivastigmine Tartrate Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Rivastigmine Tartrate Drug Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
Carbidopa & Levodopa Tablets Market - Global Forecast 2026-2032 - Product Thumbnail Image

Carbidopa & Levodopa Tablets Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 186 Pages
  • Global
From
Dementia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dementia Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 286 Pages
  • Global
From
Levodopa Market - Global Strategic Business Report - Product Thumbnail Image

Levodopa Market - Global Strategic Business Report

  • Report
  • March 2026
  • 377 Pages
  • Global
From
Neurology Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Neurology Clinical Trials - Global Strategic Business Report

  • Report
  • March 2026
  • 385 Pages
  • Global
From
5-HT1 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT1 Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Episodic Ataxia Treatment Market Report 2026 - Product Thumbnail Image

Episodic Ataxia Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Charcot-Marie-Tooth Disease Market Report 2026 - Product Thumbnail Image

Charcot-Marie-Tooth Disease Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Acute Repetitive Seizures Market Report 2026 - Product Thumbnail Image

Acute Repetitive Seizures Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Blood Brain Barrier Technologies Market Report 2026 - Product Thumbnail Image

Blood Brain Barrier Technologies Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Neurology Clinical Trials Market Report 2026 - Product Thumbnail Image

Neurology Clinical Trials Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Anti-Parkinson Drugs Market Report 2026 - Product Thumbnail Image

Anti-Parkinson Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Catalepsy Treatment Market Report 2026 - Product Thumbnail Image

Catalepsy Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Loading Indicator

The Neurological Drug market is composed of drugs used to treat diseases and disorders of the Central Nervous System (CNS). These drugs are used to treat a wide range of conditions, including Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, and stroke. CNS drugs are also used to treat psychiatric disorders, such as depression, anxiety, and schizophrenia. These drugs are typically administered orally, intravenously, or intramuscularly. The Neurological Drug market is highly competitive, with many large pharmaceutical companies competing for market share. Companies such as Pfizer, Merck, Novartis, and GlaxoSmithKline are some of the major players in the market. Other companies, such as Eli Lilly, AstraZeneca, and Sanofi, also have a presence in the market. Additionally, there are many smaller companies that specialize in the development and manufacture of CNS drugs. Show Less Read more